Mayo Clinic expert offers insight on COVID-19 |
Feb 27, 2020
Mayo Clinic News Network – COVID-19, which was first detected in Wuhan City in China, has now been identified in 37 countries, including the U.S.
U.S. cases of COVID-19 have been limited so far. The Centers for Disease Control and Prevention (CDC) has now confirmed the first possible U.S. case of "community spread," meaning the patient didn't travel anywhere known to have the virus and wasn't exposed to anyone...
"It is a Band Aid ... We need reform of the system as whole."
State sends public employees to Mexico to bring back cheaper drugs |
SALT LAKE CITY (AP) — Ann Lovell had never owned a passport before last year.
Now, the 62-year-old teacher is a frequent flier, traveling every few months to Tijuana, Mexico, to buy medication for rheumatoid arthritis — with tickets paid for by the state of Utah's public insurer.
Lovell is one of...
Feb 7, 2020
USA TODAY – A Chinese university says scientists identified the heavily trafficked pangolin as a possible intermediary host of the new coronavirus.
The coronavirus from China is believed to have originated in bats and transferred to humans through some other animal, health officials say.
The pangolin may be that key link, researchers at South China Agricultural University said Friday.
“This latest discovery will be of great significance for the prevention and control of the origin...
In nation's fastest-growing large city, caregivers just don't care right now ... |
SEATTLE (AP) — Thousands of nurses and other employees at a Seattle hospital system began a three-day strike over staffing levels and wages Tuesday, forcing administrators to close two emergency departments and bring in replacement workers.
The picketers took to the sidewalks in front of Swedish Medical Center campuses wearing clear plastic ponchos against a heavy morning rain and carrying purple signs that...
"The solution for children's identification with the opposite sex isn't to poison their bodies with megadoses of the wrong hormones, to chemically or surgically castrate and sterilize them, or to remove healthy breasts and reproductive organs," Rep. Fred Deutsch, South Dakota House of Representatives
At least six states are trying to restrict kids from getting gender reassignment treatments
January 22, 2020
CNN – State lawmakers can't stop fighting about the rights of their transgender citizens:
Their access to...
“Drug corporations are ripping people off, and anyone who wants to compete with them deserves credit.” Ben Wakana, Patients for Affordable Drugs
Jan. 22, 2020
Los Angeles Times – A group of leading U.S. health insurers, frustrated by the high cost of prescription drugs, plan to start manufacturing versions of popular generic medications, hoping the competition with pharmaceutical companies will bring down costs.
The move — the latest salvo in the escalating battle to control drug prices...
Jan 22, 2019
The Guardian – Doctors have been using a robot to treat the first person known to have been admitted to hospital in the US with a new strain of the coronavirus, as part of an effort to prevent the spread of the disease, which has killed at least 17 people in China and infected hundreds more.
The man in his 30s was admitted to the special pathogens unit in a hospital in Everett,...
Jan. 19, 2020
The Washington Post – In what may be a well-kept professional secret, physicians dread encounters with about 15 percent of their patients.
In 1978, the New England Journal of Medicine published what has become a classic on the subject: “Taking Care of the Hateful Patient.”
“Admitted or not,” wrote the author, psychiatrist James E. Groves, “the fact remains that a few patients kindle aversion, fear, despair or even downright malice in their doctors.”
Government control of healthcare has effectively removed supply-and-demand controls over drug pricing, meaning the sky is the limit on new rx costs. Here's how crony capitalist Big Pharma companies are cashing in ...
AXIOS – BioMarin Pharmaceutical is eyeing a $2-3 million price tag for its hemophilia gene therapy if it's approved, which could make it the world's most expensive drug, the Wall Street Journal reports.
Why it matters: It's a good reminder that today's pipeline...
Big Pharma insists on sending carcinogen-contaminated pills to the public
Jan 17, 2020
Salon – Big Pharma spends a small fortune every year buying politicians to make sure we can't import prescription drugs from Canada, but they're more than happy to sell us contaminated medications from countries with weak manufacturing controls and exploitable labor that ensure high profit margins.
A toxic compound that doesn't belong anywhere near medicine known as NDMA was first discovered in some blood...
"Patients are being prescribed pricey new medications that have not been tested as rigorously ... The large majority of newly approved drugs offer modest benefits over existing therapies."
Who needs testing when eager patients are waiting to pop the latest pill?
HealthDay News – New drugs are being approved by the U.S. Food and Drug Administration for patients based on less and less solid evidence, thanks to incentive programs that have been created to promote drug...
“This is a seminal moment for 23andMe”
Jan 10, 2020 |
For the first time, DNA testing company 23andMe has sold the rights to a new drug that it has developed using its customers’ data.
The deal, which is being investigated as a potential treatment for inflammatory diseases, is with Spanish pharmaceutical company Almirall.
“This is a seminal moment for 23andMe,” Emily Drabant Conley, 23AndMe’s vice-president of business development told Bloomberg. “We’ve now gone from database to discovery...
Jan 9, 2020
Ars Technica – A deadly fungal pathogen developed the ability to resist all existing antifungal drugs on three separate occasions in the United States, according to a new report.
The fungus, Candida auris, was already classified as an "urgent threat" by the Centers for Disease Control and Prevention. But the emergence of so-called "pan-resistant" strains raises additional concern, according to the report's authors, who are infectious disease specialists at the CDC and the...
Jan 9, 2020 |
Reuters – The U.S. Food and Drug Admin. approved Blueprint Medicines Corp’s oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.
The FDA’s decision makes the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST).
Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy...
HEADLINE HEALTH • PO BOX 49043 • CHARLOTTE, NC 28277
THE INFORMATION PRESENTED HERE IS FOR GENERAL EDUCATIONAL PURPOSES ONLY. YOU SHOULD ALWAYS CONSULT WITH YOUR PERSONAL PHYSICIAN REGARDING ANY PERSONAL HEALTH PROBLEM, AND YOU SHOULD ALWAYS CONSULT WITH YOUR FINANCIAL ADVISER REGARDING INVESTMENT DECISIONS. FDA DISCLOSURE: THE STATEMENTS, ARTICLES, AND PRODUCTS FEATURED IN HEADLINE HEALTH EMAILS AND AT HEADLINEHEALTH.COM HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. NO INFORMATION OR PRODUCTS APPEARING IN EMAILS OR THE WEBSITE ARE INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. MATERIAL CONNECTION DISCLOSURE: HEADLINE HEALTH MAY HAVE AN AFFILIATE RELATIONSHIP AND/OR ANOTHER MATERIAL CONNECTION TO ANY PERSONS OR BUSINESSES MENTIONED IN OR LINKED TO FROM EMAILS OR THE WEBSITE AND MAY RECEIVE COMMISSIONS FROM PURCHASES YOU MAKE ON SUBSEQUENT WEB SITES. YOU SHOULD NOT RELY SOLELY ON INFORMATION PUBLISHED BY HEADLINE HEALTH TO EVALUATE THE PRODUCT OR SERVICE BEING OFFERED. ALWAYS EXERCISE YOUR OWN DUE DILIGENCE BEFORE PURCHASING ANY PRODUCT OR SERVICE.